McKee publishes article on Insulin Glargine 

On September 13, Alexis M. McKee, MD, CDCES had an article published on “Endocrine Web,” titled “What Is Insulin Glargine and What Are Its Side Effects?”  Insulin glargine is a long-acting insulin, sometimes referred to as basal. When glargine was discovered, it was a game-changer in diabetes management because it allowed those with diabetes to stop using […]

McGill, Salam and McKee get first patient for clinical trial testing Biosense device for those with Type 1 Diabetes 

Washington University School of Medicine recently received a two-year grant of $360,000 from JDRF to fund research testing the efficacy of the Biosense handheld breath ketone monitor in persons with type 1 diabetes during care with insulin and with the addition of a sodium glucose transporter inhibitor drug.  Biosense is a non-invasive option to capillary […]

McKee publishes article on Neutral Protamine Hagedorn insulin 

On September 12, Alexis McKee, MD published an article on “EndocrineWeb,” titled “What Is the Peak Time for NPH Insulin?”  “Insulin is a lifesaving hormone that is necessary for cells in your body to absorb sugar (glucose). Depending on the type of diabetes mellitus a person has, there can be a complete absence of insulin (type […]